Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that protect against severe disease and preferably drive herd immunity. Regulators in numerous countries have authorised or approved COVID-19 vaccines for human use, with more expected to be licensed in 2021. Yet hav...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Lancet
Main Authors: Wouters, Olivier J, Shadlen, Kenneth C, Salcher-Konrad, Maximilian, Pollard, Andrew J, Larson, Heidi J, Teerawattananon, Yot, Jit, Mark
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier Ltd. 2021
Assuntos:
Health Policy
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7906643/
https://ncbi.nlm.nih.gov/pubmed/33587887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(21)00306-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares